{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T00:00:49Z","timestamp":1648512049189},"reference-count":34,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Immunoassay and Immunochemistry"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1080\/15321819.2011.603774","type":"journal-article","created":{"date-parts":[[2011,12,19]],"date-time":"2011-12-19T20:36:28Z","timestamp":1324326988000},"page":"91-113","source":"Crossref","is-referenced-by-count":1,"title":["VALIDATION OF QUANTITATIVE ELISAs FOR MEASURING ANTI-<i>YERSINIA PESTIS<\/i>F1 AND V ANTIBODY CONCENTRATIONS IN NONHUMAN PRIMATE SERA"],"prefix":"10.1080","volume":"33","author":[{"given":"C. Y.","family":"Lindsey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. S.","family":"Powell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. R.","family":"Bolt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. E.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. J.","family":"Adamovicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","reference":[{"key":"CIT0001","volume-title":"Textbooks of Military Medicine Medical Aspects of Biological Warfare","author":"Franz D. R.","year":"1997"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.3201\/eid0504.990411"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1997.03550050061035"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.73.8.5256-5261.2005"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1021\/bp050098r"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.09.052"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1016\/j.pep.2006.12.018"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1016\/j.biologicals.2008.03.001"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(96)00303-9"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1999.00859.x"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2006.09.003"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.09.052"},{"issue":"49","key":"CIT0013","doi-asserted-by":"crossref","first-page":"7748","DOI":"10.1016\/j.vaccine.2010.09.062","volume":"28","journal-title":"Vaccine"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.73.6.3598-3608.2005"},{"key":"CIT0015","unstructured":"FDA. New Drug and Biological Drug Products; Evidence needed to demonstrate effectiveness of new drugs when human efficacy studies are not ethical of feasible, in 21 CFR Parts 314 and 601, 2002.http:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfcfr\/CFRSearch.cfm?f=601.12"},{"key":"CIT0016","volume-title":"Biodefense Research Methodology and Animal Models","author":"Swearengen J. R.","year":"2006"},{"key":"CIT0017","unstructured":"Official Methods of Analysis. 2000. Available from:http:\/\/www.aoac.org\/."},{"key":"CIT0018","unstructured":"Guidance for Industry: Analytical Procedures and Methods Validation, C.a.C. Health and Human Services Food and Drug Administration, Editor, Rockville, MD, 2000."},{"key":"CIT0019","unstructured":"ICH Tripartite Harmonized Guideline Validation of Analytical Procedures: Text and Methodology Q2(R1). 2005. Available from:http:\/\/www.ich.org\/LOB\/media\/MEDIA417.pdf."},{"key":"CIT0020","unstructured":"Validation of Compendial Methods, U.S. Pharmacopeia, Editor. Rockville, MD, 2005, pp. 2748\u20132751."},{"key":"CIT0021","unstructured":"Guidance for Industry: Bioanalytical Method Validation, C.a.C. U.S. Department of Health and Human Services Food and Drug Administration, Editor, Rockville, MD, 2001."},{"key":"CIT0022","unstructured":"Quantitative Bioanalytical Methods Validation and Implementation: Best Practices for Chromatoggraphic and Ligand Binding Assays. American Association of Pharmaceutical Scientists: Arlington, VA, 2006."},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00398-06"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1016\/S1045-1056(02)00074-X"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1016\/j.biologicals.2005.08.018"},{"issue":"5","key":"CIT0026","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1093\/jaoac\/90.5.1316","volume":"90","year":"2007","journal-title":"J. AOAC Int."},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.03.011"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1023\/A:1013062600566"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.10.143"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.01.071"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.01.050"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1023\/B:PHAM.0000003390.51761.3d"},{"issue":"10","key":"CIT0033","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1128\/JCM.32.10.2441-2447.1994","volume":"32","year":"1994","journal-title":"J. Clin. Microbiol."},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1016\/S0731-7085(99)00244-7"}],"container-title":["Journal of Immunoassay and Immunochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/15321819.2011.603774","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T00:34:17Z","timestamp":1593390857000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/abs\/10.1080\/15321819.2011.603774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["10.1080\/15321819.2011.603774"],"URL":"https:\/\/doi.org\/10.1080\/15321819.2011.603774","relation":{},"ISSN":["1532-1819","1532-4230"],"issn-type":[{"value":"1532-1819","type":"print"},{"value":"1532-4230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}